New hope for teens with silent kidney damage
NCT ID NCT07405216
Summary
This study is testing whether a medication called dapagliflozin can help protect the kidneys of teenagers who have early signs of kidney disease, specifically too much protein in their urine. The trial will involve 200 adolescents in Mexico, who will receive either the real drug or a placebo pill for six months. The main goal is to see if the drug safely reduces the amount of protein in their urine, which is a key early warning sign of kidney damage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALBUMINURIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.